161 related articles for article (PubMed ID: 26320772)
21. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers.
Chan K; Roberts SA; Klimczak LJ; Sterling JF; Saini N; Malc EP; Kim J; Kwiatkowski DJ; Fargo DC; Mieczkowski PA; Getz G; Gordenin DA
Nat Genet; 2015 Sep; 47(9):1067-72. PubMed ID: 26258849
[TBL] [Abstract][Full Text] [Related]
22. Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.
Kim SH; Ahn S; Suh KJ; Kim YJ; Park SY; Kang E; Kim EK; Kim IA; Chae S; Choi M; Kim JH
Breast Cancer Res Treat; 2020 Oct; 183(3):697-704. PubMed ID: 32715441
[TBL] [Abstract][Full Text] [Related]
23. Involvement of APOBEC3A/B Deletion in Mouse Mammary Tumor Virus (MMTV)-like Positive Human Breast Cancer.
de Sousa Pereira N; Vitiello GAF; Amarante MK
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980505
[TBL] [Abstract][Full Text] [Related]
24. The 30 kb deletion in the
Klonowska K; Kluzniak W; Rusak B; Jakubowska A; Ratajska M; Krawczynska N; Vasilevska D; Czubak K; Wojciechowska M; Cybulski C; Lubinski J; Kozlowski P
Oncotarget; 2017 Sep; 8(44):76357-76374. PubMed ID: 29100317
[No Abstract] [Full Text] [Related]
25. APOBEC3B expression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation.
Cescon DW; Haibe-Kains B; Mak TW
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2841-6. PubMed ID: 25730878
[TBL] [Abstract][Full Text] [Related]
26. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
Vural S; Simon R; Krushkal J
Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
[TBL] [Abstract][Full Text] [Related]
27. Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.
Zhang Y; Delahanty R; Guo X; Zheng W; Long J
Hum Genomics; 2015 Dec; 9():34. PubMed ID: 26682542
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk.
Liu W; Ji H; Zhao J; Song J; Zheng S; Chen L; Li P; Tan X; Ding Y; Pu R; Yin J; Han X; Cao G
Int J Cancer; 2022 Jun; 150(11):1825-1837. PubMed ID: 35020946
[TBL] [Abstract][Full Text] [Related]
29. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
Buisson R; Lawrence MS; Benes CH; Zou L
Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.
Xuan D; Li G; Cai Q; Deming-Halverson S; Shrubsole MJ; Shu XO; Kelley MC; Zheng W; Long J
Carcinogenesis; 2013 Oct; 34(10):2240-3. PubMed ID: 23715497
[TBL] [Abstract][Full Text] [Related]
31. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.
Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
Nat Commun; 2024 Mar; 15(1):2370. PubMed ID: 38499542
[TBL] [Abstract][Full Text] [Related]
32. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
33. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
[TBL] [Abstract][Full Text] [Related]
34. Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
Tokunaga E; Yamashita N; Tanaka K; Inoue Y; Akiyoshi S; Saeki H; Oki E; Kitao H; Maehara Y
PLoS One; 2016; 11(12):e0168090. PubMed ID: 27977754
[TBL] [Abstract][Full Text] [Related]
35. Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population.
Ezzikouri S; Kitab B; Rebbani K; Marchio A; Wain-Hobson S; Dejean A; Vartanian JP; Pineau P; Benjelloun S
J Viral Hepat; 2013 Oct; 20(10):678-86. PubMed ID: 24010642
[TBL] [Abstract][Full Text] [Related]
36. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
[TBL] [Abstract][Full Text] [Related]
37. The
Gliniewicz K; Kluźniak W; Wokołorczyk D; Huzarski T; Stempa K; Rudnicka H; Jakubowska A; Szwiec M; Jarkiewicz-Tretyn J; Naczk M; Kluz T; Dębniak T; Gronwald J; Lubiński J; Narod SA; Akbari MR; Cybulski C
Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510234
[TBL] [Abstract][Full Text] [Related]
38. Monitoring APOBEC3A protein levels in human cancer cells.
Dananberg A; Maciejowski J
Methods Cell Biol; 2024; 182():313-327. PubMed ID: 38359985
[TBL] [Abstract][Full Text] [Related]
39. APOBEC3B deletion impacts on susceptibility to acquire HIV-1 and its advancement among individuals in western India.
Singh H; Marathe SD; Nain S; Nema V; Ghate MV; Gangakhedkar RR
APMIS; 2016 Oct; 124(10):881-7. PubMed ID: 27522954
[TBL] [Abstract][Full Text] [Related]
40. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
